Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Recombinant Asparaginase in Infants (<1 Year) With Previously Untreated Acute Lymphoblastic Leukaemia - Phase II Clinical Trial

NCT00983138 is registered in ClinicalTrials.gov with medac GmbH as lead sponsor.

NCT NCT00983138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00983138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Recombinant Asparaginase in Infants (<1 Year) With Previously Untreated Acute Lymphoblastic Leukaemia - Phase II Clinical Trial
Lead sponsor
medac GmbH
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2009
Completion date
February 28, 2011
Enrollment
12 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoid leukemia